- Article metrics
- Last updated: Wed, 24 Apr 2024 16:03:57 Z
Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series
Access & Citations
-
- 2403
- Article Accesses
-
- 0
- Web of Science
-
- 13
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.